Hevolution Foundation aims to catalyze discovery in healthspan science through innovative projects that examine root causes of aging.
Hevolution Foundation, a global nonprofit organization that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, today announced 49 new awards under its pioneering Hevolution Foundation – Geroscience Research Opportunities (HF-GRO) program.
As part of Hevolution’s mission to catalyze the healthspan scientific ecosystem and drive transformative breakthroughs in healthy aging, HF-GRO is funding promising pre-clinical research in aging biology and geroscience. Through this first wave of HF-GRO awards, Hevolution will invest up to $115 million in this first cohort of 49 selected projects over the next five years. Hevolution also plans to announce a second call for proposals under HF-GRO later this year, offering an additional $115 million to address the significant funding gaps in aging research.
Dr Felipe Sierra, Hevolution’s Chief Scientific Officer, said: “These 49 important research projects represent a significant step forward in deepening our understanding of healthy aging. Hevolution’s prime objective is to mobilize greater investment around uncovering the foundational mechanisms behind biological aging. We are steadfast in our belief that by examining the root causes of aging, rather than solely focusing on its associated diseases, we can usher in a brighter future for humanity.”
Longevity.Technology: By 2050, the global population over 60 years old is set to double to 2 billion people. Global advances in healthspan science are urgently needed, making investment in the field through initiatives like HF-GRO vital to drive scientific discovery. To date, Hevolution has committed approximately $250 million to transform the healthy aging sector, including the $40 million for specialized research and development in healthspan science recently announced at Hevolution’s Global Healthspan Summit. Hevolution is ramping up its investments to enable healthier aging for all and is now the second largest funder of aging biology research worldwide.
HF-GRO awardees include researchers at prestigious institutions across the United States, Canada, and Europe, including the US National Institute on Aging, Brigham and Women’s Hospital, the Buck Institute, the Mayo Clinic, New York University, and the University of California San Francisco, among many others. The American Federation for Aging Research is providing programmatic support for the HF-GRO program, with grantees selected through a rigorous two-stage peer-review process involving 100 experts in aging biology and geroscience.
Dr Berenice Benayoun, an HF-GRO grant recipient at the University of Southern California, says: “I am extremely honored and excited that Hevolution selected our project for funding. This is a project close to my heart, which aims at understanding why and how the female and male innate immune aging differs. This funding will support us as we start laying the foundation for a lasting improvement of women’s health throughout aging.”
Other HF-GRO grant recipients include:
- Bjorn Schumacher, University Hospital Cologne
- Derek Huffman, Albert Einstein College of Medicine
- James Kirkland, Mayo Clinic
- John Newman, Buck Institute for Research on Aging
- Leanne Jones, The Regents of the University of California San Francisco
- Marco Demaria, University Medical Center Groningen
- Pankaj Kapahi, Buck Institute for Research on Aging
- Sundeep Khosla, Mayo Clinic
- Thomas Rando, The Regents of the University of California Los Angeles
- Vadim Gladyshev, Brigham and Women’s Hospital